Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Mar;13(2):205-6.
doi: 10.1038/aja.2010.120. Epub 2010 Nov 22.

Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3

Aleyde Van Eynde  1 , Kirill Litovkin, Mathieu Bollen
Affiliations
Comment

Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3

Aleyde Van Eynde et al. Asian J Androl. 2011 Mar.

Erratum in

  • Asian J Androl. 2011 Mar;13(2):348
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of the inverse expression of PSP94 and CRISP-3 in prostate cancer and the formation of high affinity heterodimeric complexes. (a) The expression of PSP94 gradually decreases during development of prostate cancer, whereas the expression of CRISP-3 gene shows a corresponding upregulation. (b) PSP94 interacts with itself, plasma proteins and cell surface receptors, including the laminin receptor 37LRP. CRISP-3/-9, cysteine-rich secretory protein-3/-9; Ig, immunoglobulines; PSP94, prostatic secretory protein of 94 amino acids.
See this image and copyright information in PMC

Comment in

  • Is 37LRP cell surface receptor for PSP94?
    Pathak BR, Jagtap DD, Mahale SD. Pathak BR, et al. Asian J Androl. 2011 Mar;13(2):347. doi: 10.1038/aja.2010.185. Epub 2011 Feb 7. Asian J Androl. 2011. PMID: 21297657 Free PMC article. No abstract available.

Comment on

References

    1. Getzenberg RH. Novel approaches for the molecular classification of prostate cancer. Asian J Androl. 2010;12:620–2. - PMC - PubMed
    1. Whitaker HC, Warren AY, Eeles R, Kote-Jrai Z, Neal DE. The potential value of microseminoprotein-β as a prostate cancer biomarker and therapeutic target. Prostate. 2010;70:333–340. - PubMed
    1. Nam RK, Reeves JR, Toi A, Dulude H, Trachtenberg J, et al. A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis. J Urol. 2006;175:1291–7. - PubMed
    1. Kosari F, Asmann YW, Cheville JC, Vasmatzis G. Cysteine-rich secretory protein-3: a potential biomarker for prostate cancer. Cancer Epidemiol Biomarkers Prev. 2002;11:1419–26. - PubMed
    1. Bjartell AS, Johansson R, Björk T, Gadaleanu V, Lundwall A, et al. Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland. Prostate. 2006;66:591–603. - PubMed

MeSH terms